Cargando…

Severe functional tricuspid regurgitation due to wild-type transthyretin amyloid cardiomyopathy without left ventricular hypertrophy: a case report

BACKGROUND: Transthyretin amyloid cardiomyopathy (ATTR-CM) is usually characterized by left ventricular (LV) hypertrophy or LV systolic dysfunction. However, right atrial (RA) amyloidosis without LV hypertrophy, leading to severe functional tricuspid regurgitation (FTR), is extremely rare. CASE SUMM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuzoe, Hiroki, Tanaka, Hidekazu, Sato, Shunsuke, Otani, Kyoko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753527/ https://www.ncbi.nlm.nih.gov/pubmed/36530462 http://dx.doi.org/10.1093/ehjcr/ytac462

Ejemplares similares

Multimodality Assessments of Wild-Type Transthyretin Amyloid Cardiomyopathy Presenting With Eccentric Hypertrophy and Aortic Regurgitation
por: Mori, Kazuya, et al.
Publicado: (2022)

Left ventricular hypertrophy, dilatation and ejection fractions predict ventricular tachycardia in amyloid transthyretin cardiomyopathy
por: Knoll, K, et al.
Publicado: (2023)

Prognostic value of left atrial strain in patients with wild‐type transthyretin amyloid cardiomyopathy
por: Oike, Fumi, et al.
Publicado: (2021)

Correlation Between Cardiac Images, Biomarkers, and Amyloid Load in Wild‐Type Transthyretin Amyloid Cardiomyopathy
por: Morioka, Mami, et al.
Publicado: (2022)

Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
por: Oike, Fumi, et al.
Publicado: (2022)

Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy
por: Tanaka, Hidekazu, et al.
Publicado: (2020)

Clinical characteristics and natural history of wild‐type transthyretin amyloid cardiomyopathy in Japan
por: Yamada, Toshihiro, et al.
Publicado: (2020)

Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild‐type transthyretin amyloid cardiomyopathy
por: Takashio, Seiji, et al.
Publicado: (2023)

Incidence and Predictors of Ventricular Arrhythmias in Transthyretin Amyloid Cardiomyopathy
por: Knoll, Katharina, et al.
Publicado: (2023)

Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
por: Nativi-Nicolau, Jose, et al.
Publicado: (2021)

Improvement of the Left Ventricular Function after Tricuspid Valve Plasty for Traumatic Tricuspid Regurgitation
por: Okada, Taiji, et al.
Publicado: (2018)

Tricuspid Regurgitation in Left Ventricular Systolic Dysfunction: Marker or Target?
por: Margonato, Davide, et al.
Publicado: (2021)

Multimodality assessments of wild‐type transthyretin cardiac amyloidosis with no ventricular hypertrophy
por: Iwaya, Takuma, et al.
Publicado: (2022)

A simple staging system using biomarkers for wild‐type transthyretin amyloid cardiomyopathy in Japan
por: Nakashima, Naoya, et al.
Publicado: (2022)

Integrative Analyses of Genes Associated With Right Ventricular Cardiomyopathy Induced by Tricuspid Regurgitation
por: Tian, Chengnan, et al.
Publicado: (2021)

Management of Tricuspid Valve Regurgitation During Surgical Ventricular Restoration for Ischemic Cardiomyopathy
por: Arafat, Amr A., et al.
Publicado: (2023)

Endothelial Function Is Preserved in Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy
por: Hashimoto, Yu, et al.
Publicado: (2023)

Diagnosis of Transthyretin Amyloid Cardiomyopathy
por: Hafeez, Adam S., et al.
Publicado: (2020)

Hereditary transthyretin amyloid cardiomyopathy
por: Zheng, Yiliang, et al.
Publicado: (2023)

Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy
por: Devesa, Ana, et al.
Publicado: (2021)

Usefulness of automatic assessment for longitudinal strain to diagnose wild-type transthyretin amyloid cardiomyopathy
por: Usuku, Hiroki, et al.
Publicado: (2023)

Right ventricular dysfunction and tricuspid regurgitation in functional mitral regurgitation
por: Truong, Vien T., et al.
Publicado: (2021)

Progress in Cardiac Imaging Uncovers the Epidemiology of Wild-Type Transthyretin Amyloid Cardiomyopathy
por: Dorbala, Sharmila, et al.
Publicado: (2021)

Wild-type transthyretin amyloid cardiomyopathy: expect the unexpected—a case report
por: Skov, Jens Kæstel, et al.
Publicado: (2023)

Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
por: Morfino, Paolo, et al.
Publicado: (2023)

Speckle Tracking and Transthyretin Amyloid Cardiomyopathy
por: Rocha, Alexandre Marins, et al.
Publicado: (2017)

Systemic embolism in amyloid transthyretin cardiomyopathy
por: Vilches, Silvia, et al.
Publicado: (2022)

Transthyretin Amyloid Cardiomyopathy: Impact of Transthyretin Amyloid Deposition in Myocardium on Cardiac Morphology and Function
por: Nakano, Tomoya, et al.
Publicado: (2022)

Fabry Disease Presenting with Hypertrophic Cardiomyopathy and Tricuspid Regurgitation
por: Cho, Sang-Cheol, et al.
Publicado: (2016)

Early and aggressive presentation of wild-type transthyretin amyloid cardiomyopathy: A case report
por: Boda, Ilham, et al.
Publicado: (2022)

Commentary: Leaving tricuspid regurgitation unrepaired at the time of left ventricular assist device implantation?
por: D'Ambra, Michael N.
Publicado: (2020)

Multi-modality imaging in transthyretin amyloid cardiomyopathy
por: Traynor, Bryan Paul, et al.
Publicado: (2019)

Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy
por: Fontana, Marianna, et al.
Publicado: (2023)

Characteristics and prognostic implications of tricuspid regurgitation in patients with arrhythmogenic cardiomyopathy
por: Jeong, Hyeonju, et al.
Publicado: (2020)

Transcatheter edge‐to‐edge tricuspid repair for recurrence of valvular regurgitation after left ventricular assist device and tricuspid ring implantation
por: Andreas, Martin, et al.
Publicado: (2020)

A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy
por: Huda, Ahsan, et al.
Publicado: (2021)

Recovery of sinus rhythm by tafamidis in patients with wild-type transthyretin amyloid cardiomyopathy with atrial arrhythmias
por: Isotani, Yoshitaka, et al.
Publicado: (2022)

Suspicion, screening, and diagnosis of wild‐type transthyretin amyloid cardiomyopathy: a systematic literature review
por: Bay, Katrine, et al.
Publicado: (2022)

Potential Prognostic Relevance of Left-Ventricular Global Longitudinal Strain and of the Summation of the Mitral and Tricuspid Regurgitation Volume in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Mėlinytė-Ankudavičė, Karolina, et al.
Publicado: (2023)

Late Simultaneous Presentation of Left Ventricular Pseudoaneurysm and Tricuspid Regurgitation after Blunt Chest Trauma
por: Min, Ho-Ki, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j57ojimlhvfpoug4roh9bv1m5f